Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
Download PDF
May 3, 2016
/
News
Share
the Post
Related
Posts
Four Indian generic companies take sub license from MPP on daclatasvir
Availability and Pricing of Generic Sofosbuvir in India – Updated 10 September 2015
Progress report on access to hepatitis C treatment, WHO March 2018
Patent Situation of The Key Product for Treatment of Hepatitis C: DACLASTAVIR – WHO working paper, revised version, Oct 2014
Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C
18 hospitals offer free DAA therapy for treatment of Hepatitis C in Malaysia
Patent Situation of The Key Product For Treatment of Hepatitis C: SOFOSBUVIR – WHO working paper, updated 2015
Read More
Story from Ajitshwor Wangkheirakpam, Manipur, India
